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ABSTRACT
Background: Hemoglobinopathies are inherited blood disorders with an 
autosomal recessive pattern. We aimed to evaluate the frequency of mutations of 
thalassemia and hemoglobinopathies among couples referred to health centers 
of Izeh in Khuzestan Province, Iran.
Methods: This cross-sectional study was performed on 150 couples referred to 
Izeh Health Centers in 2015-2018. DNA was isolated from peripheral venous 
blood samples and then the HBB gene was analyzed by using Sanger sequencing. 
For molecular analysis of α-globin gene, multiplex Gap-PCR and ARMS-PCR 
was performed to identify mutations of α-thalassemia. 
Results: DNA analysis revealed 13 different mutations for beta thalassemia 
in studied couples. Three mutations including 36/37 (- T), IVS-II-1 (G>A) 
and IVS-I-110 (G>A) accounted for 20.7, 19.3 and 13.3% of beta thalassemia 
mutations, respectively. For alpha thalassemia; α3.7 (49.5%), -- MED (19.1 %) 
and -α4.2 (3.1%) were identified as the most common mutations. 
Conclusion: Considering common alpha and beta mutations of this geographic 
area of Iran could be useful concerning genetic counselling in of the population 
where the rate of consanguineous marriage is high.
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Introduction
Hemoglobinopathies are inherited disorders of 
hemoglobin all over the world. They are classified into 
thalassemia syndromes (α- and β thalassemia) and 
structural Hb variants resulting from mutations in the 
globin genes causing alterations in quantity and quality 
of globin chains.
Thalassemia is more prevalent in the Mediterranean 
region, North and West Africa, the Middle East, Indian 
subcontinent, southern Far East and southeastern Asia1 
β-thalassemia is commonly observed in people of Eastern 
Mediterranean region. Iran is one of the countries in 
which the frequency of β-thalassemia mutations is high 
with approximately more than two million β-thalassemia 
carriers and 25000 β thalassemia major (β-TM) patients 
.1 The highest prevalence of thalassemia mutations (about 
10 %) has been reported from Northern and Southern 
regions of Iran. Its prevalence in other regions has been 
estimated to be 4-8%.2 Mutations in the β-globin (HBB) 
gene results in decreased or absent synthesis of β-globin 
chains.3
The HBB gene is located on a short arm of chromosome 
11(11p15.5) and contains three exons with a length of 
1600 base pairs.4 The majority of β-thalassemia mutations 
result from point mutations; however, deletions have also 
been reported.5 More than 400 β-thalassemia mutations 
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have been recognized but population studies show that 
40 of these alleles are responsible for the most cases 
of β-thalassemia in the world.6, 7 The most common 
mutations leading to α-thalassemia syndromes are 
deletional variants, while point mutations and small 
insertion/deletions may rarely occur. More than 750 
different variants of α-globin genes have been reported 
worldwide. A significant aspect of alpha thalassemia 
in the Mediterranean population (including Iran) is 
the heterogeneity of the mutations, in particular, non-
deletional mutations.2 Structural hemoglobin variants 
result from point mutations in the α- or β-globin genes. 
The most widespread variants in the world are Hb S, Hb 
C, Hb E, and Hb D-Punjab.3, 4
Khuzestan province with approximately 4.000.000 
inhabitants located in the southwest Iran is a mixture 
of different ethnic populations (Arab, Persian, 
Bakhtiari, Qashqai, and Lor) due to migrations and is a 
reservoir of various mutations of thalassemia and other 
hemoglobinopathies.8 Izeh city (with dominant population 
of Bakhtiari) which is located in the North of Khuzestan 
province is the prominent ethnic population with a high 
frequency of consanguineous marriage. In the present 
study we aimed to investigate mutations of thalassemia 
and hemoglobinopathies among couples referred to health 
centers in Izeh, Khuzestan, Iran.
Materials and Methods
This descriptive study included 150 couples who were 
randomly selected from Izeh health centers during 2015 
to 2018.
Complete blood count test (CBC), Hb electrophoresis 
and measurement of Hb A2 level, measurement of serum 
iron level, ferritin, and total iron binding capacity (TIBC) 
was performed and individuals with iron deficiency 
anemia were excluded from the study. Quantification of 
Hb A2, Hb F, Hb A and other Hb variants was performed 
using Sebia Minicap system (France) according to the 
manufacturer’s instructions. The Minicap system uses the 
principle of capillary electrophoresis in free solution and 
automatically produces the electropherogram. Individuals 
with an elevated Hb A2 levels (>3.5%) were classified as 
of β-thalassemia.5
Genetic Analysis
Five ml of whole blood was collected into EDTA vacuum 
tubes (Becton Dickinson) for detection of mutations of 
thalassemia and hemoglobinopathies. Genomic DNA 
was extracted from leukocytes by conventional salting 
out method and then Sanger sequencing was performed 
to identify different types of mutations in HBB gene. 
Amplification and sequencing of the entire β-globin 
gene was performed by using two pairs of primers; 
the sequence of primers was selected according to the 
previous publications.6 Polymerase chain reaction (PCR) 
was carried out in a 25 µl reaction mixture containing 50 
ng of genomic DNA, 0.2 mM of each deoxynucleotide, 1.5 
mM of MgCl2, 1 x PCR Buffer, 0.2 mM of each primer, 
one unit of Taq-DNA polymerase and distilled water. After 
incubation at 94°C for 3 min, the amplification program 
was followed by 30 cycles at 94°C for 45 seconds, 65 °C for 
45 seconds (annealing), 1.5 min at 72 °C (extension), and 
the final extension at 72°C for 7 min. After electrophoresis 
of the PCR products on a 1% agarose gel, sequencing of 
the PCR products was performed using an ABI 3730 xl 
DNA Sequencer (Applied Biosystems Inc, Foster City, 
CA). For molecular analysis of α-globin gene, multiplex 
Gap-PCR was used first to evaluate common α-thalassemia 
mutations and deletions in Iran (-- MED, -a 3.7, -α 20.5 and 
–a 4.2). If any mutation was not detected, ARMS-PCR was 
performed to screen for -α CD19, - α CS and α 5nt deletion.
Statistical Analysis
Data was analyzed with SPSS software (version 
18.0), using descriptive statistical tests (mean, SD, and 
frequency for quantitative data including Hb, MCV and 
MCH and Hb A2.
Results
Among 150 couples, 102 couples (68%) had low MCV 
and MCH levels (MCV= 77.0±1.6 and MCH= 22.8. ±1.9) 
along with Hb A2 ≥3.5% and thus were identified as 
β-thalassemia carriers. 
The couples with normal blood indices or those who 
had low MCV (<80 Fl) and MCH (<27 pg) with normal 
levels Hb A2 (Hb A2: 2.3±0.5) were considered as 
carriers for other hemoglobinopathies or other cases 
of thalassaemia such as α- thalassaemia. It was found 
that 64 of 300 (21.3%) of individuals were heterozygous 
for Hb S, Hb D, Hb C and or co-inheritance of an Hb 
variant and β-thalassemia (Table 1). Mean values of red 
cell parameters and hemoglobin electrophoresis were 
listed in Table 2. 
Mutation analysis revealed 13 different types mutations 
in the HBB gene. Three alleles; CD 36/37 (- T), IVS-
II-1 (G>A) and IVS-I-110 (G>A) with a frequency of 
20.7%, 19.3% and 13.3%, respectively were the most 
common. Other mutations such as +20 (C>T) in the 5’ 
untranslated region, -28 (A>C), and IVS- II-745 (C>G) 
were also observed.
Table 1: Distribution of haemoglobin variants among all couples
Haemoglobin variant Number % in 300 cases
Hb S trait (Hb AS) 20 6.6
Hb S/Beta thalassemia 4 1.33
Hb C trait (Hb AC) 16 5.33
Hb C/Beta thalassemia 7 2.33
Hb D trait (Hb AD) 13 4.33
HBE trait (Hb AE) 4 1.33
Total 64 21.33
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The three common deletions of α thalassemia were -α3.7 
(49.5%), --MED (19.1%) and -α4.2 (3.1%). The results of 
allele frequency of thalassaemic subjects are summarized 
in Table 2.
It was found that 21.3% of individuals were heterozygous 
for Hb S, Hb D, Hb C and or co-inheritance of an Hb 
variant and β-thalassemia (Table 3). The genetic analysis 
for these Hb variants revealed mutations in the β-globin 
gene, HBB: c.20A>T), HBB: c.67G>C and HBB: c.19G>A 
corresponding to Hb S, Hb D and Hb C, respectively. 
Discussion
Thalassemia syndromes are common genetic disorders with 
a great variety of different mutations in Iranian population. 
Recent studies have indicated the presence of more than 
50 mutations in the β-globin gene in most provinces 
of Iran.7, 8 In a study from Iran in Khuzestan province; 
Galehdari et al in 2010 found 42 different mutations 
associated with β-thalassemia and identified eight common 
β-globin variants, namely, Hb S [β6(A3)Glu→Val], Hb C 
[β6(A3)Glu→Lys], Hb D-Punjab [β121(GH4)Glu→Gln] 
and Hb O-Arab [β121 (GH4) Glu→Lys]. The distribution 
of thalassemia mutations in their study was typical of a 
heterogenous population with three mutations as the most 
common including [codons 36/37 (-T), IVS-II-1 (G>A) and 
IVS-I-110 (G>A)] at a frequency of 20.5, 20.0 and 14.2%, 
respectively.9 In the present study, 13 β mutations were 
found which the most common mutations were similar to 
the abovementioned report. 
In another study performed by Hosseini Nezhad et al., 
the three most common mutations consisted of IVS-II-1 
(G>A) (26%), IVS-I-1 (G>A) (16%), and IVS-I-110 (G>A) 
(14%).10 These findings were also consistent with other 
studies from Khuzestan. In a study by Sayahi et al. on 
spectrum of thalassemia among voluntary couples in city 
of Shushtar, CD 36/37 (-T), IVS II-1 (G>A) and IVS I-110 
(G>A) were identified as the most common mutations.11
 Dehghani et al., reported two mutations; CD 36/37 (- T) 
(%13.9) and IVS- II-1 (G>A) (10.1%) as the most prevalent 
mutations of β-thalassemia from Ahwaz, the capital of 
Khuzestan province.12
In another study from Khuzestan province, the most 
common mutations were: IVSІІ-1(25%), IVSІ-110 (16%), 
CD 36/37(15%), CD5(9%), IVSІ-S(8%), IVSІ-6(7%), 
IVSІ-1(5%) and CD39(5%). IVSII-I was the most frequent 
mutation in this survey.13
Doosti et al. evaluated mutations of the alpha and 
beta-thalassemia among carriers of thalassemia referred 
for prenatal diagnosis in Shadegan City. CD36/37(-T) 
(38.61%), IVS- II-1 (G>A) (24.75%) and CD (-AA) 
(12.87%) were reported as the most common mutations.14
In another study from Khuzestan province, some 
different mutations were reported which included IVS-
II-745(C>G), +20(C>T in the 5′ untranslated region) and 
IVS-II-745(C>G).15
Asadi and colleagues found the same mutations as 
our study from other cities of Khuzestan province.16 
Comparison of frequency of β-thalassemia mutations 
among different cities in Khuzestan province is shown 
in Table 4.
Our findings revealed some similarities and differences 
with other parts of Iran (Table 5). For example, the 
mutation in codons 36/37(-T) has been identified as the 
most common β-thalassemia mutation in the majority of 
Iran’s provinces. It was found first in Lorestan and then in 
Isfahan with a frequency of 33% and 9.7%, respectively.17 
While its frequency is low in Hamedan and Hormozgan 
province.8
Table 2: Mean values (mean±SD) of red cell parameters and hemoglobin electrophoresis
Variant Frequency
of patients
MCV MCH HbA HbA2 HbF Other
Hb S carrier 24(8.0%) 80.5±5.2 27.3.±5.9 82.2±4.8 3.3±.6 0.75±0.8 13.5±3.7
Hb D carrier 13(4.33%) 82.7±2.6 28.4.±3.2 79.7±1.6 2.4±.1.6 1.2±0.2 16.2±3.8
Hb C carrier 23(7.66%) 80.3±1.6 27.1.±2.5 74.6±5.7 2.2±1.8 1.7±0.3 21±10.5
Hb E 4 (1.33%) 81.5±3.6 22.2.±1.5 80.4±7.2 2.1±.5 0.5±0.9 15.3±7.6
Table 3: Summary of frequencies of Mutant alleles in all β-thalassemia subjects
n Mutation Type Number of Mutant alleles Origin Frequency of allele 
1 CD 36/37(-T) β0 62 Kurdish, Iranian 20.66%
2 IVS-II-1 (G>A) β0 58 Mediterranean 19.33%
3 IVS-I-110 (G>A) β+ 40 Mediterranean 13.33%
4 IVS- II-745 (C>G) β+ 34 Mediterranean 11.33%
5 5UTR+20(C>T) β+ 32 Iranian 10.66%
6 -28 (A>C) β+ 28 Kurdish 9.33
7 CD 82/83 (-G) β0 12 Azerbaijani 4.0
8 CD8/9 (+G) β0 8 Asian, Indian 2.66%
9 IVS-I (-del 25nt) β0 6 Med East 2%
10 CD8 (-AA) β0 6 Mediterranean 2%
11 IVS-I-5 (G>C) β0 6 Mediterranean 2%
12 IVSI-1 (G>A) β0 4 Mediterranean 1.33%
13 CD39 (C>T) β0 4 Mediterranean 1.33 %
Total 300 100%
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The second common mutation in our study was IVS-
II-1 (G>A), known as the Mediterranean type, found in 
countries such as Syria, Lebanon and Palestine.18 This 
mutation is frequently observed in Iran with a frequency 
of %66 in the northern provinces (Mazandaran, Gilan, 
and Golestan),19 21% in the north western provinces 
(Azerbaijan and Ardabil),2 31.3% in Qazvin20 and 25.61% 
in Hamedan.6 
IVS-I-110 is the third most prevalent mutation in our 
study which has been found in North west of Iran with 
a frequency of 18%.2 Interestingly, this mutation has not 
been reported in Hormozgan according to the literature.8 
IVS-I-110 has been also reported in countries such as 
Lebanon and Turkey with frequency of 33.0% and 39%, 
respectively.21
We also found less common mutations of IVS- II-
745(C>G), +20(C>T in the 5′ untranslated region, -28 
(A>C) with frequencies of 11.33, 10.66 and 9.33%, 
respectively. 
The codons 8/9 (+G) is an Asian-Indian allele which 
was found in the most parts of Iran with a frequency of 
13.5% in Kermanshah,22 15.7% in Kurdistan and West 
Azerbaijan,23 and 14.5% in North-west of Iran;2 whereas, 
it has a low frequency in Khuzestan (3%),9 similar to the 
statistics of our study. 
IVS-I-5 (G>C) which has been observed as the second 
most prevalent variant in Iran with a frequency of 69% in 
south Iran (Hormozgan) and 72% in south east of Iran,8 
was uncommon in our study and other reports from 
Khuzestan province (5%). 
Other detected mutations were CD82/83(-G), IVSI 
(-del25nt), CD39 (C>T), IVSI-1 (G>A) and CD 8 (–AA), 
which accounted for 11.3% of mutant alleles. This finding 
was approximately similar to the study by Galehdari et al. 
which reported a frequency of 15.8% for these mutations 
(Table 3).9 
The most prevalent deletions for α thalassemia were -α 
3.7, -α 4.2, and -- MED. The deletions that most commonly 
lead to α-thalassemia whole over the world include; -α3.7, 
-α4.2, Mediterranean (--MED) and Southeast Asian deletions 
(--SEA). The most common deletions of α-thalassemia in 
the Iranian population are −α3.7, -α4.2, -α20.5 and -- MED.24-29
In a study by Khosravi et al., the -a 3.7 and -- MED 
deletions were reported as the most common in Bakhtiari 
population of the Khuzestan province.30 Deletion of -α3.7 
was reported with high prevalence (79.6%) among alpha 
thalassemia carriers in Shushtar city.11
Nezhad et al. showed that -α3.7/αα (50%), Med/ααthal 
(12%), and -α4.2/αα (10%) were the most prevalent α 
deletional mutations in southwestern Iran.10
Table 4: Frequency of detected mutations in β-thalassemia subjects in comparison to other provinces of Iran
Mutation Izeh% 
(n=300) 
Khuzestan% 
(n=1241) 
Lorestan% 
(n=130) 
Bushehr (%) 
(n 120)
Kermanshah% 
(n=370) 
1 codons 36/37 (-T) 20.66 20.54 33.80 0.0 7.84
2 IVS-II-1 (G>A) 19.33 20.01 27.70 13.7 32.9
3 IVS-I-110(G>A) 13.33 14.18 11.50 5.9 8.38
4 IVS- II-745(C>G) 11.33 1.30 1.60 3.4 0.0
5 5’UTR +20 (C>T) 10.66 1 0.0 0.0 0.0
6 -28 (A>C) 9.33 0.82 0.0 0.0 0.0
7 CD 82/83 (-G) 4.0 2.10 0.0 0.0 1.08
8 CD 8/9 (+G) 2.66 3 10.80 8.8 13.51
9 IVSI (-del 25nt) 2 2.54 0.76 24.0 0.0
10 CD39 (C>T) 2 3.50% 0.0 3.4 2.97
11 IVS-I-1 (G>A) 2 3.7% 0.0 8.8 4.59
12 CD8 (-AA) 1.33 3.0% 0.0 0.0 5.94
13 IVS-I-5 (G>C) 1.33 5.18 4.70 7.8 2.16
Table 5: Frequency of detected mutations in β-thalassemia subjects in comparison to other cities in Khuzestan (All numbers are 
percentage)
Mutation Izeh Masjed soleiman Izeh/Baq-Malek Shadegan Abadan Shoushtar Ahvaz 
Codons 36/37 (T) 20.66 26.7 22.70 38.61 15 23.4 20.54
IVS-II-1 (G>A) 19.33 22 19.23 24.75 25 23.4 20.01
IVS-I-110(G>A) 13.33 16.27 8.46 5.94 16 10 14.18
CD 82/83 (-G) 11.33 12.7 0.0 1.98 0.0 9 2.10
IVS-II-745(C>G) 10.66 6.97 11.53 1.60 0.0 0.9 1.30
5’UTR +20 (C>T) 9.33 8.1 11.53 0.0 0.0 0.9 1
CD 8/9 (+G) 4.0 3.48 0.0 1.98 0.0 0.0 3
CD39 (C>T) 2.66 3.48 1.54 0.99 5 9 3.50%
IVS I (-del 25nt) 2 2 3.06 1.98 - 4.5 2.54
CD39 (C>T) 2 2 1.54 0.99 - 0.9 3.5
IVS-I-1 (G>A) 2 2 1.92 0.99 5 - 3.73
CD8 (-AA) 1.33 1.33 6.15 12.87 - 1.88 3.00
IVS-I-5 (G>C) 1.33 1.33 1.54 0.99 8 0.9 5.18
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Meanwhile, -α3.7 (57.1 %), -- MED (17.4%), -α4.2 (3.1%) 
and -α20.5 (1.5%) are reported as common mutations of 
α thalassemia in Masjed Soleiman, Khuzestan.31
Conclusion
In this study, we found 13 different mutations in addition 
to previous ones in Khuzestan province. This could due to 
the dominance of specific mutations in certain geographic 
areas. 36/37 (- T), IVS-II-1 (G>A) and IVS-I-110 mutations 
of beta gene and also IVS-II-745 (C>G), +20 (C>T) in the 
5’ untranslated region , and -28 (A>C, Codons 82/83 (–G) 
were reported with high frequency in Izeh city. These 
mutations in this area should be considered in genetic 
counselling and thalassemia prevention strategies.
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